02342oam 2200625 450 991071665160332120211215140110.044-686(CKB)5470000002523650(OCoLC)1259692367(EXLCZ)99547000000252365020210712d2021 ua 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierExamining Emergent Biosolutions' failure to protect public health and public funds hearing before the Select Subcommittee on the Coronavirus Crisis of the Committee on Oversight and Reform, House of Representatives, One Hundred Seventeenth Congress, first session, May 19, 2021Washington :U.S. Government Publishing Office,2021.1 online resource (iii, 44 pages)Access ID (govinfo): CHRG-117hhrg44686."Serial no. 117-23."Examining Emergent Biosolutions' failure to protect public health and public funds COVID-19 (Disease)VaccinationUnited StatesCOVID-19 Pandemic, 2020-United StatesVaccines industryGovernment policyUnited StatesVaccines industrySubsidiesUnited StatesVaccinesUnited StatesCOVID-19 (Disease)VaccinationfastVaccines industryGovernment policyfastVaccines industrySubsidiesfastUnited StatesfastLegislative hearings.fastLegislative hearings.lcgftCOVID-19 (Disease)VaccinationCOVID-19 Pandemic, 2020-Vaccines industryGovernment policyVaccines industrySubsidiesVaccinesCOVID-19 (Disease)Vaccination.Vaccines industryGovernment policy.Vaccines industrySubsidies.4.OV 2:117-23GPOGPOGPOOCLCOOCLCFOCLCQDWPGPOBOOK9910716651603321Examining Emergent Biosolutions' failure to protect public health and public funds3498239UNINA